Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2021 | R33 | CA247744 | RFA-CA-20-018 | GARTNER, ZEV JORDAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO | Universal Sample Multiplexing for Single Cell Analysis | Active |
2022 | R33 | CA267258 | RFA-CA-21-004 | LEE, ABRAHAM P | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy | Active |
2022 | R33 | CA269015 | CA21-004 | ADEY, ANDREW | OREGON HEALTH & SCIENCE UNIVERSITY | Accessible high-throughput single-cell genome sequencing | Active |
2021 | R33 | CA251006 | RFA-CA-20-020 | HAUN, JERED BRACKSTON | UNIVERSITY OF CALIFORNIA-IRVINE | Microfluidic tumor tissue processing platform for single cell diagnostics | Active |
2023 | R61 | CA278531 | RFA-CA-22-001 | SHIRURE, VENKTESH | UNIVERSITY OF CALIFORNIA AT DAVIS | Microfluidic technology to isolate tumoricidal T-cells from peripheral blood | Active |
2022 | R33 | CA258012 | CA21-004 | KARGINOV, ANDREI V | UNIVERSITY OF ILLINOIS AT CHICAGO | Optogenetic Control of Tumor Initiation and Tumor Progression in vivo | Active |
2021 | R33 | CA255893 | RFA-CA-20-018 | SEELIG, GEORG | UNIVERSITY OF WASHINGTON | Joint receptor and protein expression immunophenotyping through split-pool barcoding | Active |
2022 | R21 | CA269099 | RFA-CA-21-003 | YAKOVLEV, VLADISLAV V | TEXAS ENGINEERING EXPERIMENT STATION | Molecular and cellular imaging of bone biopsies using AI augmented deep UV Raman microscopy | Active |
2022 | R21 | CA269091 | CA21-005 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions | Active |
2021 | R33 | CA256102 | RFA-CA-20-018 | GREENBERG, JOEL | DUKE UNIVERSITY | Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens | Active |
2022 | R21 | CA272351 | RFA-CA-21-003 | SOPER, STEVEN ALLAN | UNIVERSITY OF KANSAS LAWRENCE | Molecular Sub-typing Breast Cancer Patients using a Liquid Biopsy | Active |
2022 | R33 | CA269094 | CA21-004 | MOELLERING, RAYMOND E | UNIVERSITY OF CHICAGO | Single-Cell Protein Activity Profiling in Breast Cancer Cells and Tissues | Active |
2021 | R33 | CA257878 | RFA-CA-20-018 | HANSEN, ANDERS SEJR | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer | Active |
2023 | R33 | CA281802 | RFA-CA-22-002 | LABAER, JOSHUA | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck | Active |
2022 | R21 | CA261775 | CA21-003 | LIN, QIAO | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Practical Approach to Tumor-Specific Aptamers for B-Cell Hematologic Malignancies | Active |
2021 | R33 | CA258016 | RFA-CA-20-018 | LIU, XUEFENG | OHIO STATE UNIVERSITY | Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics | Active |
2020 | R21 | CA240220 | RFA-CA-19-019 | ALEXANDRAKIS, GEORGIOS | UNIVERSITY OF TEXAS ARLINGTON | Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy | Active |
2022 | R21 | CA267245 | RFA-CA-21-005 | SHIBATA, DARRYL K | UNIVERSITY OF SOUTHERN CALIFORNIA | Photolithographic Tumor DNA Isolation | Active |
2022 | R33 | CA269100 | CA21-004 | CHIU, BRIAN C-H | UNIVERSITY OF CHICAGO | A highly sensitive linear amplification based DNA methylation profiling technique for clinical cancer research | Active |
2020 | R33 | CA247739 | RFA-CA-19-020 | MATRIX BHATNAGAR, PARIJAT | SRI INTERNATIONAL | T-cell Biofactories For Targeting Extracellular Matrix | Active |
2023 | R61 | CA278398 | RFA-CA-22-001 | GAO, XIAOJING J | STANFORD UNIVERSITY | Program the Immune System against RAS-driven Cancer | Active |
2022 | R21 | CA269103 | CA21-003 | BLAINEY, PAUL CLARK | BROAD INSTITUTE, INC. | Stitch-seq for genome-wide pooled genomic screening with RNA-seq readout | Active |
2021 | R21 | CA251043 | CA20-017 | HOSHIKA, SHUICHI | FOUNDATION FOR APPLIED MOLECULAR EVOLUTN | High Quality Proteins with Multiple Post Translational Modifications | Active |
2020 | R21 | CA251042 | RFA-CA-19-021 | GUPTA, GAUTAM | UNIVERSITY OF LOUISVILLE | Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens | Active |
2023 | R33 | CA272271 | RFA-CA-22-002 | CUNNINGHAM, BRIAN T | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN | Rapid, simple, and ultrasensitive quantitation of KRAS ctDNA at the point of care using CRISPR/Cas amplification and digital resolution biosensor microscopy | Active |
2022 | R21 | CA272345 | RFA-CA-21-003 | KNOWLES, DAVID ARTHUR | NEW YORK GENOME CENTER | A CRISPR/Cas13 approach for identifying individual transcript isoform function in cancer | Active |
2023 | R33 | CA278469 | RFA-CA-22-002 | JI, HANLEE P | STANFORD UNIVERSITY | Single cell modeling of cancer mutations | Active |
2023 | R61 | CA278452 | RFA-CA-22-001 | SHAH, NEEL H | COLUMBIA UNIV NEW YORK MORNINGSIDE | A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates | Active |
2023 | R61 | CA278445 | RFA-CA-22-001 | DHAKAL, SOMA | VIRGINIA COMMONWEALTH UNIVERSITY | Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers | Active |
2023 | R33 | CA281602 | RFA-CA-22-002 | MEYER, KATHRYN D | DUKE UNIVERSITY | A High-Throughput Screening Platform to Discover RNA Methylation Inhibitors | Active |
2021 | R21 | CA261734 | CA20-019 | AKSAN, ALPTEKIN | UNIVERSITY OF MINNESOTA | Novel cryopreservation method for stabilization of manufactured therapeutic cells | Active |
2022 | R33 | CA272357 | RFA-CA-21-004 | PAN, TAO | UNIVERSITY OF CHICAGO | Transfer RNA sequencing and application to cancer research and clinics | Active |
2022 | R33 | CA272321 | RFA-CA-21-004 | WANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY | A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies | Active |
2022 | R21 | CA261643 | RFA-CA-21-005 | TANG, SINDY KAM-YAN | STANFORD UNIVERSITY | A micro-dissection platform for generating uniform-sized patient-derived tumor organoids (PDOs) for personalized cancer therapy | Active |
2021 | R21 | CA263147 | CA20-017 | BHARGAVA, ROHIT | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN | Spectroscopy Assisted Laser Microdissection | Active |
2020 | R21 | CA240185 | RFA-CA-19-019 | LI, WEI | TEXAS TECH UNIVERSITY | Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip | Active |
2023 | R61 | CA278559 | RFA-CA-22-001 | LU, YUE | UNIVERSITY OF UTAH | Vesicle Epitope Transcript sequencing (VET-seq): Droplet-based Multiomic Profiling Platform for Single Vesicle Analysis | Active |
2023 | R61 | CA278459 | RFA-CA-22-001 | PRATX, GUILLEM | STANFORD UNIVERSITY | A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer | Active |
2021 | R33 | CA252158 | CA20-018 | ZENG, YONG | UNIVERSITY OF FLORIDA | Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles | Active |
2020 | R21 | CA247638 | RFA-CA-19-019 | LIANG, FU-SEN | CASE WESTERN RESERVE UNIVERSITY | Spatiotemporal Epitranscriptome Editing Technology | Active |
2021 | R43 | CA261362 | PAR-18-303 | ALLEN, JEFFREY KEITH | TUMORGEN, INC. | Capture and Characterization of Highly Metastatic Cancer Cell Clusters in Transit from Lung Cancer Patient Whole Blood Specimens. | Active |
2022 | R21 | CA257942 | RFA-CA-21-003 | GIBBS, SUMMER LYNNE | OREGON HEALTH & SCIENCE UNIVERSITY | A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors | Active |
2021 | R33 | CA256086 | CA20-018 | JIANG, NING JENNY | UNIVERSITY OF PENNSYLVANIA | A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells | Active |
2005 | R33 | CA112141 | RFA-CA-05-002 | BAKER, JAMES R | UNIVERSITY OF MICHIGAN AT ANN ARBOR | PHOTONIC CRYSTAL FIBER PROBE FLUORESCENCE BIOSENSING | Complete |
2008 | R21 | CA132815 | RFA-CA-07-037 | WEIER, HEINZ-ULRICH GUENTER | UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB | ACCELERATING CANCER RESEARCH WITH SINGLE CELL ARRAYS | Complete |
2011 | R21 | CA160052 | RFA-CA-10-005 | LAWRENCE, DAVID A | WADSWORTH CENTER | HOLISTIC DIAGNOSTICS OF HOST DURING DEVELOPMENT OF CANCER | Complete |
2015 | R33 | CA191143 | RFA-CA-14-004 | MANALIS, SCOTT R | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | SINGLE CELL GROWTH ASSAY FOR RESIDUAL CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA | Complete |
2018 | R33 | CA217702 | RFA-CA-17-013 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity | Complete |
1999 | R43 | CA081958 | PAR-98-066 | HAGEN, FREDERICK S | ICOGENEX CORPORATION | AFFINITY AND TRANSCRIPTASE TECHNOLOGIES | Complete |
2001 | R44 | CA081965 | PAR-99-101 | BITTER, GRANT A. | BITTECH, INC. | DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS | Complete |